Tech Company Financing Transactions

Somaxon Pharmaceuticals Funding Round

Domain Associates, CDIB Bioscience and Montreux Equity Partners invested in a $23 million Series B venture round for Somaxon Pharmaceuticals. The round was announced on 6/15/2004.

Transaction Overview

Company Name
Somaxon Pharmaceuticals
Announced On
6/15/2004
Transaction Type
Venture Equity
Amount
$23,000,000
Round
Series B
Investors

Domain Associates (Lead Investor) (Jesse Treu)

CDIB Bioscience

Montreux Equity Partners (Daniel Turner)

Scale Venture Partners (Louis Bock)

Proceeds Purpose
This investment will help Somaxon achieve its next clinical milestone with our lead product, SO-101 (low dose doxepin), which is entering into Phase II clinical development for the treatment of insomnia. The investment also allows us to pursue additional product in-licensing and acquisition opportunities.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
440 Stevens Avenue 200
Solana Beach, CA 92075
USA
Phone
(858) 876-6500
Website
www.somaxon.com
Email Address
[email protected]
Overview
Somaxon Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products in the area of neuropsychiatry and related diseases.
Profile
Somaxon Pharmaceuticals LinkedIn Company Profile
Social Media
Somaxon Pharmaceuticals Company Twitter Account
Company News
Somaxon Pharmaceuticals News
Facebook
Somaxon Pharmaceuticals on Facebook
YouTube
Somaxon Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Richard Pascoe
  Richard Pascoe LinkedIn Profile  Richard Pascoe Twitter Account  Richard Pascoe News  Richard Pascoe on Facebook
Chief Financial Officer
Tran Nguyen
  Tran Nguyen LinkedIn Profile  Tran Nguyen Twitter Account  Tran Nguyen News  Tran Nguyen on Facebook
VP - General Counsel
Matthew Onaitis
  Matthew Onaitis LinkedIn Profile  Matthew Onaitis Twitter Account  Matthew Onaitis News  Matthew Onaitis on Facebook
VP - General Counsel
Matthew Onaitis
  Matthew Onaitis LinkedIn Profile  Matthew Onaitis Twitter Account  Matthew Onaitis News  Matthew Onaitis on Facebook
VP - Operations
Brian Dorsey
  Brian Dorsey LinkedIn Profile  Brian Dorsey Twitter Account  Brian Dorsey News  Brian Dorsey on Facebook
VP - Sales
Michael Allen
  Michael Allen LinkedIn Profile  Michael Allen Twitter Account  Michael Allen News  Michael Allen on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/15/2004: RiskMetrics Group venture capital transaction
Next: 6/16/2004: Tarari venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC transactions reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.